Metabolic effects of bezafibrate in mitochondrial disease
- Submitting institution
-
Coventry University
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 31239334
- Type
- D - Journal article
- DOI
-
10.15252/emmm.201911589
- Title of journal
- EMBO Molecular Medicine
- Article number
- e11589
- First page
- -
- Volume
- 12
- Issue
- 3
- ISSN
- 1076-1551
- Open access status
- Compliant
- Month of publication
- February
- Year of publication
- 2020
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
16
- Research group(s)
-
-
- Citation count
- 12
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Professor Jakovljevic made substantial contribution to the conception and design of the study parts related to evaluation of clinical outcomes (i.e. cardiac function and exercise capacity) before and after the bezafibrate intervention. He was responsible for the organisation of the conduct of the study related to assessment of these clinical outcomes, analysis and interpretation of these study data. Professor Jakovljevic provided a critique of the manuscript for important intellectual content.
- Non-English
- No
- English abstract
- -